22nd May 2026, Friday

TechPharus

Latest Posts

HealthTech News

  • Ebola risk now at highest level in DR Congo, says WHO
    on May 22, 2026 at 7:00 pm

    The risk from the deadly Ebola outbreak has been raised to the highest level for the Democratic Republic of Congo, the World Health Organization said Friday, as the toll continued to rise.

  • How a father’s obesity affects his children’s metabolism
    on May 22, 2026 at 6:40 pm

    The scientific literature already contains robust evidence that obesity, whether maternal or paternal, can lead to metabolic changes in offspring that increase their risk of developing diseases. A new study published in the journal Nature Communications reveals the mechanism by which this “inheritance” is transmitted to the embryo by the father via the sperm.

  • Overloaded brain cleanup cells may mark severe multiple sclerosis progression
    on May 22, 2026 at 6:20 pm

    Researcher Daan van der Vliet, together with colleagues from the Netherlands Institute for Neuroscience, Leiden University, and Utrecht University, has discovered an important mechanism that may be linked to severe progression of multiple sclerosis (MS). In brain tissue from patients with rapidly progressing MS, they found large numbers of abnormal immune cells overloaded with fat droplets. The study offers new leads for treatments as well as biomarkers that could better predict disease progression. The work is published in the journal Nature Neuroscience.

  • Psilocybin cuts nerve pain for weeks and boosts gabapentin in mice
    on May 22, 2026 at 6:20 pm

    A single dose of psilocybin, the active compound in magic mushrooms, reduces nerve pain for up to a month and makes a widely used painkiller work more effectively, University of Reading research has found.

  • A once-daily pill takes aim at measles, croup and other dangerous viruses
    on May 22, 2026 at 6:00 pm

    A new oral antiviral drug candidate has been developed for the treatment of diseases caused by orthoparamyxoviruses, such as measles and croup syndrome, according to a study published by researchers in the Center for Translational Antiviral Research at Georgia State University. The paper in Science Advances identifies clinical candidate GHP-88310 for urgently needed, improved orthoparamyxovirus disease management in rodent and non-rodent animal models of infection. Orthoparamyxoviruses, such as human parainfluenzaviruses, measles virus and emerging henipaviruses, pose a significant threat to human health.